Nicolau, J.; SanchÃs, P.; Tamayo, M.I.; Pérez-Bec, G.; Sfondrini, G.; Grimalt, M.; Masmiquel, L.
Is the Presence of a Depressive Disorder a Risk Factor for Worse Metabolic Outcomes Among Patients with Type 2 Diabetes Treated with GLP-1 Analogs? Diabetology 2025, 6, 68.
https://doi.org/10.3390/diabetology6070068
AMA Style
Nicolau J, SanchÃs P, Tamayo MI, Pérez-Bec G, Sfondrini G, Grimalt M, Masmiquel L.
Is the Presence of a Depressive Disorder a Risk Factor for Worse Metabolic Outcomes Among Patients with Type 2 Diabetes Treated with GLP-1 Analogs? Diabetology. 2025; 6(7):68.
https://doi.org/10.3390/diabetology6070068
Chicago/Turabian Style
Nicolau, Joana, Pilar SanchÃs, MarÃa Isabel Tamayo, Guadalupe Pérez-Bec, Guido Sfondrini, Mireia Grimalt, and LluÃs Masmiquel.
2025. "Is the Presence of a Depressive Disorder a Risk Factor for Worse Metabolic Outcomes Among Patients with Type 2 Diabetes Treated with GLP-1 Analogs?" Diabetology 6, no. 7: 68.
https://doi.org/10.3390/diabetology6070068
APA Style
Nicolau, J., SanchÃs, P., Tamayo, M. I., Pérez-Bec, G., Sfondrini, G., Grimalt, M., & Masmiquel, L.
(2025). Is the Presence of a Depressive Disorder a Risk Factor for Worse Metabolic Outcomes Among Patients with Type 2 Diabetes Treated with GLP-1 Analogs? Diabetology, 6(7), 68.
https://doi.org/10.3390/diabetology6070068
